Form 4: AHR Executive's Stock Transactions & RSU Vesting

American Healthcare REIT's EVP, GC & Secretary, Mark E. Foster, reported vesting of restricted stock units, tax-related share withholdings, and a sale of common stock on March 25, 2026.

Summary

• Mark E. Foster, Executive Vice President, General Counsel & Secretary of American Healthcare REIT, Inc., reported multiple transactions on March 25, 2026.
• 7,435 Restricted Stock Units (RSUs) from an award granted on March 25, 2024, vested and converted into common stock.
• An additional 3,673 Restricted Stock Units (RSUs) from an award granted on March 25, 2025, also vested and converted into common stock.
• A new award of 6,510 time-based RSUs was granted on March 25, 2026, which will vest ratably on March 10, 2027, 2028, and 2029.
• The Issuer withheld 3,783 shares and 1,869 shares of common stock to satisfy tax obligations associated with the RSU vesting, with the shares valued at $48.25 each.
• Foster sold 2,000 shares of common stock at a price of $48.55 per share, a transaction executed pursuant to a Rule 10b5-1 trading plan adopted on December 19, 2025.
• Following these reported transactions, Foster directly beneficially owns 56,121 shares of common stock and 21,294 Restricted Stock Units (comprising 7,436, 7,348, and 6,510 units from various awards).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, typical for executive compensation and personal financial management, with no direct positive or negative implications for company operations or outlook.

Positives

• The vesting of 7,435 and 3,673 Restricted Stock Units indicates the realization of previously granted equity compensation.
• A new award of 6,510 time-based Restricted Stock Units demonstrates continued equity compensation for the executive.

Negatives

• The sale of 2,000 shares of common stock by an executive reduces their direct ownership in the company.
• A total of 5,652 shares were withheld by the Issuer to cover tax obligations, reducing the net shares received from vesting.

Future Outlook

Future vesting events for Mark E. Foster's Restricted Stock Units are scheduled for March 25, 2027, March 10, 2028, March 25, 2028, and March 10, 2029, subject to continuous employment.

Industry Context

StockSavvy.ai notes that insider transactions, such as RSU vesting, tax withholdings, and pre-planned sales under Rule 10b5-1, are routine occurrences for executives managing their equity compensation and personal financial planning. These types of filings typically do not reflect a change in the company's operational performance or strategic direction.

Stakeholder Impact

• Shareholders may observe a minor increase in the public float due to the sale of 2,000 shares, though the overall impact is likely negligible given the routine nature of the transaction.

Next Steps

• Continued vesting of previously awarded Restricted Stock Units on March 25, 2027, March 10, 2028, March 25, 2028, and March 10, 2029.

Key Dates

Recommendation

This Form 4 details routine insider transactions related to equity compensation and a pre-planned sale under a Rule 10b5-1 plan. It does not provide new information about American Healthcare REIT's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transactions reflect an executive managing their compensation, which is a normal course of business and does not indicate a shift in company fundamentals.

Keywords

American Healthcare REIT, AHR, Mark E. Foster, Form 4, Insider Transaction, Restricted Stock Unit, RSU Vesting, Share Sale, 10b5-1 Plan, Equity Compensation